Myeloproliferative neoplasm: Difference between revisions
No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
Line 16: | Line 16: | ||
{{Myeloproliferative disease}} | {{Myeloproliferative disease}} | ||
{{CMG}} | {{CMG}} | ||
{{SK}} Myeloproliferation, myeloproliferative Disorders, myeloproliferative neoplasm | |||
==[[Myeloproliferative disease overview|Overview]]== | ==[[Myeloproliferative disease overview|Overview]]== | ||
Revision as of 20:58, 12 February 2015
Template:DiseaseDisorder infobox
Myeloproliferative Neoplasm Microchapters |
Differentiating myeloproliferative neoplasm from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Myeloproliferative neoplasm On the Web |
American Roentgen Ray Society Images of Myeloproliferative neoplasm |
Directions to Hospitals Treating Myeloproliferative neoplasm |
Risk calculators and risk factors for Myeloproliferative neoplasm |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Myeloproliferation, myeloproliferative Disorders, myeloproliferative neoplasm
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Myeloproliferative disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies